The Medicaid approved drug list, also known as the Medicaid formulary, is a curated list of prescription drugs reimbursed by the Medicaid program for eligible low-income individuals and families. It varies by state and is updated annually based on clinical evidence, cost-effectiveness, and federal guidelines.
Each state administers its own Medicaid program under federal oversight, resulting in differences in which drugs are included. The list is not static-it reflects changes in medical research, drug pricing, and regulatory approvals. For example, a new cancer treatment may be added in one state within months of FDA approval, while another state may delay inclusion due to budget constraints.
Drug coverage is determined through a tiered system. Medications are assigned to tiers based on cost and clinical necessity. Tier 1 typically includes generic drugs with the lowest out-of-pocket costs. Tier 3 and 4 cover brand-name and specialty drugs, often requiring higher copays or prior authorization. A patient's specific plan details their coverage level and cost-sharing responsibilities.
States must follow federal requirements set by the Centers for Medicare & Medicaid Services (CMS) to maintain eligibility for federal funding. CMS mandates that states cover certain categories of drugs, including those for HIV, hepatitis C, and antipsychotic treatments. However, states have discretion over additional medications beyond these mandatory categories.
When a physician prescribes a medication, pharmacies verify coverage using the Medicaid formulary. If a drug is not listed, the provider may request a waiver or seek an alternative. Prior authorization is required for many high-cost or high-risk drugs. This process involves submitting clinical documentation to prove medical necessity, which can take several days to approve.
For example, a 62-year-old woman with type 2 diabetes in Texas was prescribed Jardiance, a brand-name diabetes medication. Her pharmacy checked the state's formulary and found it on Tier 3. She was required to pay $35 for a 30-day supply, but her provider submitted a prior authorization request citing improved kidney outcomes. After review, the state approved coverage with no copay.
Medicaid formularies are structured into tiers, each reflecting different levels of cost and access. The following table outlines standard tier classifications and typical examples:
| Tier | Drug Type | Typical Cost Share | Examples |
|---|---|---|---|
| 1 | Preferred generics | $0-$5 | Levothyroxine, lisinopril |
| 2 | Non-preferred generics | $5-$10 | Metformin XR (non-preferred version) |
| 3 | Brand-name drugs | $10-$30 | Atorvastatin (Lipitor), Humira |
| 4 | Specialty and biologics | $30-$100+ | Enbrel, Keytruda |
Some states use a "preferred drug list" within their formulary, encouraging providers to prescribe lower-cost alternatives. For instance, California's Medi-Cal program requires pharmacists to offer generic equivalents unless a clinical exception is documented. Failure to do so results in denied claims.
A non-obvious distinction: not all drugs on the Medicaid approved drug list are automatically available at all pharmacies. Some rural clinics or independent pharmacies may not carry certain specialty drugs due to distribution contracts or inventory limits. Patients may need to use a network pharmacy or obtain a mail-order option.
Many assume the Medicaid approved drug list is uniform across all states. That is incorrect. Coverage for the same drug can differ between states. For example, Ozempic (semaglutide) is covered in New York for weight management in patients with obesity and type 2 diabetes, but not in Florida unless the patient has a documented diagnosis of cardiovascular disease.
Another misconception is that being on the list guarantees free access. While some drugs are fully covered, others require copays, especially for brand-name or newer medications. A patient in Michigan paying $25 monthly for a Tier 3 antidepressant may not realize that a generic alternative on Tier 1 costs $5 and is equally effective.
Patients sometimes confuse the Medicaid approved drug list with the Medicare Part D formulary. These are separate programs with different rules. Medicare Part D covers retirees and disabled individuals aged 65+, while Medicaid serves low-income populations regardless of age. A person receiving both benefits may see different coverage for the same drug depending on which program applies.
In 2023, a 45-year-old man in Oregon with chronic migraines was prescribed Nurtec ODT (rimegepant), a newer migraine prevention drug. His primary care provider recommended it after failed trials with older treatments. The pharmacy checked the Oregon Health Authority's Medicaid formulary and found the drug on Tier 4.
He was told the copay would be $60 per month. He contacted his case manager, who initiated a prior authorization request citing documented failure of three previous preventive therapies. The request was approved after two weeks, reducing his cost to $10. The provider later confirmed that the drug had been added to the preferred list for chronic migraine treatment in the state's updated formulary.
This case illustrates how access depends on both formulary status and administrative processes. It also shows that patients should not assume coverage based on a doctor's recommendation alone.
While some online resources claim to list all Medicaid-covered drugs nationally, these are often outdated or incomplete. The most accurate source remains the state-specific formulary. Always verify coverage before filling a prescription to avoid unexpected costs.
Understanding the Medicaid approved drug list ensures better access to essential medications. It is not a single national list but a changing, state-by-state structure shaped by federal standards, budget decisions, and clinical evidence. Knowing how it works helps patients and providers make informed choices about treatment options.